Sun Pharma gains on HC order

Image
BS Reporter Mumbai
Last Updated : Jan 21 2013 | 12:29 AM IST

Sun Pharma touched a high of Rs 1,459 and finally ended at Rs 1,436, up 2% from the previous close. The counter clocked volumes of 234,664 shares on the NSE today.

Cadila Healthcare erased all its losses and soared to a high of Rs 590. The scrip finally ended at Rs 589, up 3% from its previous close. The counter witnessed trades of 70,167 shares on the NSE.
_________________________________________

(Updated at 1040hrs)

Sun Pharma has gained after the Madras High Court  has stopped Zydus Cadila (Cadila Healthcare) from selling anti-depressant drug, Venz (venlafaxine), in the domestic market for the time being, on the basis of the trademark complain lodged by the company. 

The stock opened at Rs 1,407 and soared to a high of Rs 1,423. The stock is now trading at Rs 1,422, up 1.5% from the previous close. The counter has clocked volumes of 4,058 shares on the BSE.

Cadila Healthcare opened at Rs 560 and slipped to a low of Rs 557, down 2% from the previous close. The stock has however recoverd and is now at flat at Rs 570. The counter has clocked volumes of 1,428 shares on the BSE.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 11 2009 | 4:01 PM IST

Next Story